{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T05:30:40Z","timestamp":1734499840923,"version":"3.30.2"},"reference-count":25,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T00:00:00Z","timestamp":1731715200000},"content-version":"vor","delay-in-days":15,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nefrolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.nefroe.2024.11.006","type":"journal-article","created":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T07:00:16Z","timestamp":1732604416000},"page":"877-884","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Preclinical gout is common in the patient with stage 3\u20135 chronic kidney disease. Relevance of musculoskeletal ultrasound"],"prefix":"10.1016","volume":"44","author":[{"given":"Enrique","family":"Calvo-Aranda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Barrio Nogal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boris Anthony","family":"Blanco Caceres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Peiteado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Novella-Navarro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugenio","family":"De Miguel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaime","family":"Arroyo Palomo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Alc\u00e1zar Arroyo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Antonio","family":"Mart\u00edn Navarro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milagros","family":"Fernandez Lucas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martha Elizabeth","family":"Diaz Dominguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco Antonio","family":"Vaca Gallardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elda","family":"Besada Estevez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leticia","family":"Lojo Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nefroe.2024.11.006_bib0005","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/nrrheum.2014.124","article-title":"Improving cardiovascular and renal outcomes in gout: what should we target?","volume":"10","author":"Richette","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.nefroe.2024.11.006_bib0010","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-031550","article-title":"Gout and the risk of advanced chronic kidney disease in the UK health system: a national cohort study","volume":"9","author":"Stack","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.nefroe.2024.11.006_bib0015","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0002-9343(87)90441-4","article-title":"Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study","volume":"82","author":"Campion","year":"1987","journal-title":"Am J Med"},{"key":"10.1016\/j.nefroe.2024.11.006_bib0020","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1001\/archinte.1987.00370040027005","article-title":"Is thiazide-produced uric acid elevation harmful? Analysis of data from the Hypertension Detection and Follow-up Program","volume":"147","author":"Langford","year":"1987","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.nefroe.2024.11.006_bib0025","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1136\/annrheumdis-2017-212288","article-title":"Relationship between serum urate concentration and clinically evident incident gout: an individual participant data analysis","volume":"77","author":"Dalbeth","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.nefroe.2024.11.006_bib0030","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1136\/annrheumdis-2019-215315","article-title":"2018 updated European League Against Rheumatism evidence-based recommendations for the diagnosis of gout","volume":"79","author":"Richette","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.nefroe.2024.11.006_bib0035","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1136\/annrheumdis-2014-205304","article-title":"Hyperuricaemia and gout: time for a new staging system?","volume":"73","author":"Dalbeth","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.nefroe.2024.11.006_bib0040","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1136\/annrheumdis-2019-215933","article-title":"Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions of disease states of gout","volume":"78","author":"Bursill","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.nefroe.2024.11.006_bib0045","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/ndt\/gfu352","article-title":"Prevalence and correlates of gout in a large cohort of patients with chronic kidney disease: the German Chronic Kidney Disease (GCKD) study","volume":"30","author":"Jing","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nefroe.2024.11.006_bib0050","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13075-015-0610-9","article-title":"Gout and risk of chronic kidney disease and nephrolithiasis: meta-analysis of observational studies","volume":"17","author":"Roughley","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.nefroe.2024.11.006_bib0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0050046","article-title":"Reduced glomerular function and prevalence of gout: NHANES 2009\u201310","volume":"7","author":"Krishnan","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.nefroe.2024.11.006_bib0060","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1053\/j.ajkd.2007.05.013","article-title":"Relationship of uric acid with progression of kidney disease","volume":"50","author":"Chonchol","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nefroe.2024.11.006_bib0065","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1053\/j.ajkd.2008.12.021","article-title":"Uric acid and long-term outcomes in CKD","volume":"53","author":"Madero","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nefroe.2024.11.006_bib0070","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1093\/ckj\/sfac075","article-title":"Uric acid lowering for slowing CKD progression after the CKD-FIX trial: a solved question or still a dilemma?","volume":"15","author":"Leoncini","year":"2022","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.nefroe.2024.11.006_bib0075","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1136\/annrheumdis-2014-206397","article-title":"Urate crystal deposition in asymptomatic hyperuricaemia and symptomatic gout: a dual energy CT study","volume":"74","author":"Dalbeth","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.nefroe.2024.11.006_bib0080","doi-asserted-by":"crossref","first-page":"R4","DOI":"10.1186\/ar3223","article-title":"Joint and tendon subclinical involvement suggestive of gouty arthritis in asymptomatic hyperuricemia: an ultrasound controlled study","volume":"13","author":"Pineda","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.nefroe.2024.11.006_bib0085","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1136\/ard.2011.154997","article-title":"Diagnosis of gout in patients with asymptomatic hyperuricaemia: a pilot ultrasound study","volume":"71","author":"De Miguel","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.nefroe.2024.11.006_bib0090","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1080\/15257770802136040","article-title":"Asymptomatic hyperuricemia: impact of ultrasonography","volume":"27","author":"Puig","year":"2008","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"10.1016\/j.nefroe.2024.11.006_bib0095","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1002\/art.40572","article-title":"Brief report: monosodium urate monohydrate crystal deposits are common in asymptomatic sons of patients with gout: the sons of gout study","volume":"70","author":"Abhishek","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.nefroe.2024.11.006_bib0100","first-page":"264","article-title":"Articular cartilage of knee and first MTP joint are the preferred sites to find double contour sign as an evidence of urate crystal deposition in asymptomatic hyperuricemic individuals","volume":"43","author":"Bhadu","year":"2018","journal-title":"Acta Reumatol Port"},{"key":"10.1016\/j.nefroe.2024.11.006_bib0105","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/acr.23082","article-title":"Ultrasound features of the first metatarsophalangeal joint in gout and asymptomatic hyperuricemia: comparison with normouricemic individuals","volume":"69","author":"Stewart","year":"2017","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.nefroe.2024.11.006_bib0110","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.3899\/jrheum.150366","article-title":"Assessing elementary lesions in gout by ultrasound: results of an OMERACT patient-based agreement and reliability exercise","volume":"42","author":"Terslev","year":"2015","journal-title":"J Rheumatol"},{"key":"10.1016\/j.nefroe.2024.11.006_bib0115","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/rheumatology\/keaa366","article-title":"Ultrasound for the diagnosis of gout-the value of gout lesions as defined by the Outcome Measures in Rheumatology ultrasound group","volume":"60","author":"Christiansen","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.nefroe.2024.11.006_bib0120","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.semarthrit.2019.01.004","article-title":"Prevalence and discrimination of OMERACT-defined elementary ultrasound lesions of gout in people with asymptomatic hyperuricaemia: a systematic review and meta-analysis","volume":"49","author":"Stewart","year":"2019","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.nefroe.2024.11.006_bib0125","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000528200","article-title":"Musculoskeletal ultrasound evaluates renal injury and predicts renal outcome in patients with gout","volume":"9","author":"Li","year":"2022","journal-title":"Kidney Dis"}],"container-title":["Nefrolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2013251424002050?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2013251424002050?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T12:11:02Z","timestamp":1734437462000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2013251424002050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S2013251424002050"],"URL":"https:\/\/doi.org\/10.1016\/j.nefroe.2024.11.006","relation":{},"ISSN":["2013-2514"],"issn-type":[{"type":"print","value":"2013-2514"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preclinical gout is common in the patient with stage 3\u20135 chronic kidney disease. Relevance of musculoskeletal ultrasound","name":"articletitle","label":"Article Title"},{"value":"Nefrolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nefroe.2024.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.nefro.2023.06.001","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Sociedad Espa\u00f1ola de Nefrolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}